141 related articles for article (PubMed ID: 19093898)
21. α-Ketoglutaric Acid-Modified Carbonate Apatite Enhances Cellular Uptake and Cytotoxicity of a Raf- Kinase Inhibitor in Breast Cancer Cells through Inhibition of MAPK and PI-3 Kinase Pathways.
Hossain SM; Shetty J; Tha KK; Chowdhury EH
Biomedicines; 2019 Jan; 7(1):. PubMed ID: 30609867
[TBL] [Abstract][Full Text] [Related]
22. Citrate- and Succinate-Modified Carbonate Apatite Nanoparticles with Loaded Doxorubicin Exhibit Potent Anticancer Activity against Breast Cancer Cells.
Mehbuba Hossain S; Chowdhury EH
Pharmaceutics; 2018 Mar; 10(1):. PubMed ID: 29534497
[TBL] [Abstract][Full Text] [Related]
23. Inorganic nanoparticles in diagnosis and treatment of breast cancer.
Núñez C; Estévez SV; Del Pilar Chantada M
J Biol Inorg Chem; 2018 May; 23(3):331-345. PubMed ID: 29453558
[TBL] [Abstract][Full Text] [Related]
24. Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies.
Nounou MI; ElAmrawy F; Ahmed N; Abdelraouf K; Goda S; Syed-Sha-Qhattal H
Breast Cancer (Auckl); 2015; 9(Suppl 2):17-34. PubMed ID: 26462242
[TBL] [Abstract][Full Text] [Related]
25. Multi-small molecule conjugations as new targeted delivery carriers for tumor therapy.
Shan L; Liu M; Wu C; Zhao L; Li S; Xu L; Cao W; Gao G; Gu Y
Int J Nanomedicine; 2015; 10():5571-91. PubMed ID: 26366078
[TBL] [Abstract][Full Text] [Related]
26. A critical review of lipid-based nanoparticles for taxane delivery.
Feng L; Mumper RJ
Cancer Lett; 2013 Jul; 334(2):157-75. PubMed ID: 22796606
[TBL] [Abstract][Full Text] [Related]
27. Development of biodegradable polymer based tamoxifen citrate loaded nanoparticles and effect of some manufacturing process parameters on them: a physicochemical and in-vitro evaluation.
Sahana B; Santra K; Basu S; Mukherjee B
Int J Nanomedicine; 2010 Sep; 5():621-30. PubMed ID: 20856837
[TBL] [Abstract][Full Text] [Related]
28. The Photodynamic Effect of Different Size ZnO Nanoparticles on Cancer Cell Proliferation In Vitro.
Li J; Guo D; Wang X; Wang H; Jiang H; Chen B
Nanoscale Res Lett; 2010 Apr; 5(6):1063-71. PubMed ID: 20671778
[TBL] [Abstract][Full Text] [Related]
29. Relevance of biophysical interactions of nanoparticles with a model membrane in predicting cellular uptake: study with TAT peptide-conjugated nanoparticles.
Peetla C; Rao KS; Labhasetwar V
Mol Pharm; 2009; 6(5):1311-20. PubMed ID: 19243206
[TBL] [Abstract][Full Text] [Related]
30. Surface engineering of inorganic nanoparticles for imaging and therapy.
Nam J; Won N; Bang J; Jin H; Park J; Jung S; Jung S; Park Y; Kim S
Adv Drug Deliv Rev; 2013 May; 65(5):622-48. PubMed ID: 22975010
[TBL] [Abstract][Full Text] [Related]
31. Inorganic nanoparticles for predictive oncology of breast cancer.
Yezhelyev M; Yacoub R; O'Regan R
Nanomedicine (Lond); 2009 Jan; 4(1):83-103. PubMed ID: 19093898
[TBL] [Abstract][Full Text] [Related]
32. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
[TBL] [Abstract][Full Text] [Related]
33. Functionalization of inorganic nanoparticles for bioimaging applications.
Erathodiyil N; Ying JY
Acc Chem Res; 2011 Oct; 44(10):925-35. PubMed ID: 21648430
[TBL] [Abstract][Full Text] [Related]
34. Inorganic nanoparticles for cancer imaging and therapy.
Huang HC; Barua S; Sharma G; Dey SK; Rege K
J Control Release; 2011 Nov; 155(3):344-57. PubMed ID: 21723891
[TBL] [Abstract][Full Text] [Related]
35. Inorganic nanomedicine--part 1.
Sekhon BS; Kamboj SR
Nanomedicine; 2010 Aug; 6(4):516-22. PubMed ID: 20417313
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
